Back

Human iPSC 4R tauopathy model uncovers modifiers of tau propagation

Parra Bravo, C.; Giani, A. M.; Madero-Perez, J.; Zhao, Z.; Samelson, A. J.; Wong, M. Y.; Evangelisti, A.; Fan, L.; Pozner, T.; Mercedes, M.; Ye, P.; Patel, T.; Yarahmady, A.; Carling, G.; Lee, V. M. Y.; Sharma, M.; Mok, S.-A.; Luo, W.; Zhao, M.; Kampmann, M.; Gong, S.; Gan, L.

2023-06-22 neuroscience
10.1101/2023.06.19.544278 bioRxiv
Show abstract

Tauopathies are age-associated neurodegenerative diseases whose mechanistic underpinnings remain elusive, partially due to lack of appropriate human models. Current human induced pluripotent stem cell (hiPSC)-derived neurons express very low levels of 4-repeat (4R)-tau isoforms that are normally expressed in adult brain. Here, we engineered new iPSC lines to express 4R-tau and 4R-tau carrying the P301S MAPT mutation when differentiated into neurons. 4R-P301S neurons display progressive Tau inclusions upon seeding with Tau fibrils and recapitulate features of tauopathy phenotypes, including shared transcriptomic signatures, autophagic body accumulation, and impaired neuronal activity. A CRISPRi screen of genes associated with Tau pathobiology identified over 500 genetic modifiers of Tau-seeding-induced Tau propagation, including retromer VPS29 and the UFMylation cascade as top modifiers. In AD brains, the UFMylation cascade is altered in neurofibrillary-tangle-bearing neurons. Inhibiting the UFMylation cascade suppressed seeding-induced Tau propagation. This model provides a powerful platform to identify novel therapeutic strategies for 4R tauopathy.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.